Literature DB >> 16890490

Towards a molecular understanding of human diseases using Dictyostelium discoideum.

Robin S B Williams1, Katrina Boeckeler, Ralph Gräf, Annette Müller-Taubenberger, Zhiru Li, Ralph R Isberg, Deborah Wessels, David R Soll, Hannah Alexander, Stephen Alexander.   

Abstract

The social amoeba Dictyostelium discoideum is increasingly being used as a simple model for the investigation of problems that are relevant to human health. This article focuses on several recent examples of Dictyostelium-based biomedical research, including the analysis of immune-cell disease and chemotaxis, centrosomal abnormalities and lissencephaly, bacterial intracellular pathogenesis, and mechanisms of neuroprotective and anti-cancer drug action. The combination of cellular, genetic and molecular biology techniques that are available in Dictyostelium often makes the analysis of these problems more amenable to study in this system than in mammalian cell culture. Findings that have been made in these areas using Dictyostelium have driven research in mammalian systems and have established Dictyostelium as a powerful model for human-disease analysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16890490     DOI: 10.1016/j.molmed.2006.07.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  45 in total

Review 1.  Dictyostelium finds new roles to model.

Authors:  Jeffrey G Williams
Journal:  Genetics       Date:  2010-07       Impact factor: 4.562

2.  Evidence of an evolutionarily conserved LMBR1 domain-containing protein that associates with endocytic cups and plays a role in cell migration in dictyostelium discoideum.

Authors:  Jessica S Kelsey; Nathan M Fastman; Daphne D Blumberg
Journal:  Eukaryot Cell       Date:  2012-02-03

3.  The Legionella pneumophila effector SidJ is required for efficient recruitment of endoplasmic reticulum proteins to the bacterial phagosome.

Authors:  Yancheng Liu; Zhao-Qing Luo
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

4.  A bacterial symbiont is converted from an inedible producer of beneficial molecules into food by a single mutation in the gacA gene.

Authors:  Pierre Stallforth; Debra A Brock; Alexandra M Cantley; Xiangjun Tian; David C Queller; Joan E Strassmann; Jon Clardy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

5.  CP250, a novel acidic coiled-coil protein of the Dictyostelium centrosome, affects growth, chemotaxis, and the nuclear envelope.

Authors:  Rosemarie Blau-Wasser; Ursula Euteneuer; Huajiang Xiong; Berthold Gassen; Michael Schleicher; Angelika A Noegel
Journal:  Mol Biol Cell       Date:  2009-08-19       Impact factor: 4.138

Review 6.  Directional sensing during chemotaxis.

Authors:  Christopher Janetopoulos; Richard A Firtel
Journal:  FEBS Lett       Date:  2008-04-29       Impact factor: 4.124

7.  Heterogeneities Shape Passive Intracellular Transport.

Authors:  Patrick Witzel; Maria Götz; Yann Lanoiselée; Thomas Franosch; Denis S Grebenkov; Doris Heinrich
Journal:  Biophys J       Date:  2019-06-18       Impact factor: 4.033

8.  Global transcriptional responses to cisplatin in Dictyostelium discoideum identify potential drug targets.

Authors:  Nancy Van Driessche; Hannah Alexander; Junxia Min; Adam Kuspa; Stephen Alexander; Gad Shaulsky
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

9.  Pharmacogenetics of resistance to Cisplatin and other anticancer drugs and the role of sphingolipid metabolism.

Authors:  Stephen Alexander; William S Swatson; Hannah Alexander
Journal:  Methods Mol Biol       Date:  2013

10.  An ancestral non-proteolytic role for presenilin proteins in multicellular development of the social amoeba Dictyostelium discoideum.

Authors:  Marthe H R Ludtmann; Grant P Otto; Christina Schilde; Zhi-Hui Chen; Claire Y Allan; Selina Brace; Philip W Beesley; Alan R Kimmel; Paul Fisher; Richard Killick; Robin S B Williams
Journal:  J Cell Sci       Date:  2014-01-24       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.